INDV: Indivior PLC

INDV新闻

• 14:22 KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data
• 22:09 ESCO Technologies Stock, PayPay, Amer Sports Among 18 New Stocks On IBD Watchlists
• 22:26 Agnico Eagle Mines Stock, CF Industries, 8 Others Enter IBD Watchlists
• 17:13 Theravance Stock Declines Around 17% in Three Months: Here's Why
• 13:40 TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
• 13:35 NTLA Stock Rises 20% in 3 Months: Here's What You Should Know
• 14:09 CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
• 16:37 KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
• 16:31 RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
• 16:14 ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
• 22:29 Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists
• 13:44 SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria
• 22:56 ASML, An AI Megatrend Star, Leads 8 Newcomers To Best Stock Lists
• 18:54 IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
• 16:04 KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
• 13:55 How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%
• 14:29 ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
• 15:23 Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
• 15:57 SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema
• 17:06 IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints
• 16:44 RARE Rises as FDA Accepts Resubmitted BLA for Sanfilippo Syndrome
• 15:10 Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics
• 14:11 OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study
• 14:00 5 Small Drug Stocks to Buy as Sector Recovery Gains Strength